SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001553350-22-000012
Filing Date
2022-01-05
Accepted
2022-01-05 06:03:02
Documents
35
Period of Report
2022-01-04
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT htbx_8k.htm   iXBRL 8-K 27024
2 PRESS RELEASE htbx_ex99z1.htm EX-99.1 34095
6 GRAPHIC himage_001logo.jpg GRAPHIC 8788
7 GRAPHIC image_022.jpg GRAPHIC 48572
8 GRAPHIC image_023.jpg GRAPHIC 259785
9 GRAPHIC image_024.jpg GRAPHIC 140308
10 GRAPHIC image_025.jpg GRAPHIC 133947
11 GRAPHIC image_026.jpg GRAPHIC 148286
12 GRAPHIC image_027.jpg GRAPHIC 157165
13 GRAPHIC image_028.jpg GRAPHIC 168576
14 GRAPHIC image_029.jpg GRAPHIC 108373
15 GRAPHIC image_030.jpg GRAPHIC 157172
16 GRAPHIC image_031.jpg GRAPHIC 146158
17 GRAPHIC image_032.jpg GRAPHIC 157320
18 GRAPHIC image_033.jpg GRAPHIC 136923
19 GRAPHIC image_034.jpg GRAPHIC 178191
20 GRAPHIC image_035.jpg GRAPHIC 119970
21 GRAPHIC image_036.jpg GRAPHIC 167217
22 GRAPHIC image_037.jpg GRAPHIC 144427
23 GRAPHIC image_038.jpg GRAPHIC 165924
24 GRAPHIC image_039.jpg GRAPHIC 163004
25 GRAPHIC image_040.jpg GRAPHIC 179415
26 GRAPHIC image_041.jpg GRAPHIC 171772
27 GRAPHIC image_042.jpg GRAPHIC 134865
  Complete submission text file 0001553350-22-000012.txt   4649897

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE htbx-20220104.xsd EX-101.SCH 3040
4 XBRL LABEL FILE htbx-20220104_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE htbx-20220104_pre.xml EX-101.PRE 22369
29 EXTRACTED XBRL INSTANCE DOCUMENT htbx_8k_htm.xml XML 3603
Mailing Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560
Business Address 627 DAVIS DRIVE SUITE 400 MORRISVILLE NC 27560 919-240-7133
HEAT BIOLOGICS, INC. (Filer) CIK: 0001476963 (see all company filings)

IRS No.: 262844103 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35994 | Film No.: 22509319
SIC: 2834 Pharmaceutical Preparations